On September 20, 2010
Management by Suicide Pact: Elan CEO Fends Off Dissident Investors With Poison Pills
With an internal probe awarding Elan’s management a clean bill of health, the stock ought to be rebounding nicely. Here’s why it’s stuck below $5.
No tags for this post.
0 Comments